Corentec Co

Corentec Co Equity Ratio

The Equity Ratio of Corentec Co (104540.KQ) as of Oct 16, 2026 is 45.57 %. In the previous year, Equity Ratio was 38.64 % — a change of 17.94% (higher).

Equity Ratio

45.57 %

YoY

17.94%

Last updated:

Equity Ratio of Corentec Co is 2025 45.57 % . Equity Ratio of Corentec Co was 2024 38.64 % . It decreases by 17.94% higher compared to the previous year.

The Corentec Co Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
37.48 KRW
Jan 1, 2019
47.69 KRW
Jan 1, 2020
48.27 KRW
Jan 1, 2021
47.63 KRW
Jan 1, 2022
38.27 KRW
Jan 1, 2023
39.42 KRW
Jan 1, 2024
38.64 KRW
Jan 1, 2025
45.57 KRW
The Corentec Co Equity Ratio history
YEAREquity RatioYoY
45.57 %+17.94%
38.64 %-1.98%
39.42 %+3.02%
38.27 %-19.66%
47.63 %-1.32%
48.27 %+1.21%
47.69 %+27.23%
37.48 %-30.60%
54.01 %-13.87%
62.70 %-20.30%
78.68 %+14.85%
68.50 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co Ltd is a South Korean company headquartered in Cheonan, operating within the Health Care sector. The company went public on March 5, 2013, as indicated by its IPO date. Corentec specializes in the manufacture and sale of artificial articulations, focusing on orthopedic products. Its product portfolio includes hip systems such as primary systems, hemi-arthroplasty systems, and revision systems, featuring cementless and cemented femoral stems, acetabular cups, and bearing systems. The company also offers knee products, comprising primary fixed and mobile type systems, revision knee systems, and augment systems. Additionally, Corentec provides spine products, including pedicle screws and peek cages. The firm markets its hip products under the BENCOX brand, while knee and spine products are sold under the LOSPA and LOSPA IS brand names, respectively. Corentec serves both domestic and international markets, distributing its products globally. The company's website is www.corentec.com. Corentec's business model centers on developing and commercializing orthopedic solutions for joint replacement and spinal care, with a focus on quality and innovation in medical devices. The company's operations are based in Cheonan, South Korea, and it has maintained a presence in the health care industry since its IPO in 2013. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Equity Ratio of Corentec Co is 45.57 % in 2025.

Equity Ratio of Corentec Co changed from 38.64 % to 45.57 %, representing a 17.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Corentec Co since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Corentec Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Corentec Co

All Key Metrics — Corentec Co